Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021.
作者信息
Agúndez José A G, García-Martín Elena
机构信息
Universidad de Extremadura, Institute of Molecular Pathology Biomarkers, University of Extremadura, Cáceres, Spain.
出版信息
Front Pharmacol. 2022 Apr 14;13:907131. doi: 10.3389/fphar.2022.907131. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021.社论：药物遗传学与药物基因组学洞察：2021年
Front Pharmacol. 2022 Apr 14;13:907131. doi: 10.3389/fphar.2022.907131. eCollection 2022.
2
Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.临床药物基因组学检测在下一代测序时代：精准医学的挑战和机遇。
Expert Rev Mol Diagn. 2018 May;18(5):411-421. doi: 10.1080/14737159.2018.1461561. Epub 2018 Apr 23.
3
Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.不同监管机构和研究联盟使用基于下一代测序的临床药物基因组学数据，在精神疾病的基因组指导方面存在差异和相似之处。
Pharmacol Res. 2021 May;167:105538. doi: 10.1016/j.phrs.2021.105538. Epub 2021 Mar 9.
4
Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.解析主要监管机构中肿瘤临床药物基因组学指南实践的异质性。
Pharmacogenomics. 2020 Nov;21(17):1247-1264. doi: 10.2217/pgs-2020-0056. Epub 2020 Oct 30.
5
Building an information system to facilitate pharmacogenomics clinical translation with clinical decision support.建立一个信息系统，通过临床决策支持来促进临床转化。
Pharmacogenomics. 2022 Jan;23(1):35-48. doi: 10.2217/pgs-2021-0110. Epub 2021 Nov 17.
6
Technologies for Pharmacogenomics: A Review.《药物基因组学技术：综述》
Genes (Basel). 2020 Dec 4;11(12):1456. doi: 10.3390/genes11121456.
7
Evaluation of the need for pharmacogenomics testing among physicians in the West Bank of Palestine.评估巴勒斯坦西岸医生对药物基因组学检测的需求。
Drug Metab Pers Ther. 2021 Jun 7;36(4):289-294. doi: 10.1515/dmpt-2021-0121.
8
Towards population-specific pharmacogenomics in the era of next-generation sequencing.迈向基于新一代测序的个体化药物基因组学时代。
Drug Discov Today. 2021 Aug;26(8):1776-1783. doi: 10.1016/j.drudis.2021.04.015. Epub 2021 Apr 20.
9
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.经济效用：基层医疗环境中用于精神卫生保健的组合药物基因组学与药物成本节约
Clin Ther. 2017 Mar;39(3):592-602.e1. doi: 10.1016/j.clinthera.2017.01.022. Epub 2017 Feb 21.
10
Perception and knowledge of pharmacogenetics among Brazilian psychiatrists.巴西精神科医生对药物遗传学的认知和了解。
Psychiatry Res. 2021 Dec;306:114238. doi: 10.1016/j.psychres.2021.114238. Epub 2021 Oct 11.
引用本文的文献
1
Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023.社论：药物遗传学与药物基因组学洞察：2023年
Front Pharmacol. 2025 Jan 3;15:1540478. doi: 10.3389/fphar.2024.1540478. eCollection 2024.
2
Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine.解锁治疗诱导细胞因子反应的潜力：照亮癌症精准医学的新途径。
Curr Oncol. 2024 Feb 23;31(3):1195-1206. doi: 10.3390/curroncol31030089.
本文引用的文献
1
Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.敲除人芳香胺 N-乙酰基转移酶 1（NAT1）在 MDA-MB-231 乳腺癌细胞中导致储备能力增加、最大线粒体能力和糖酵解储备能力增加。
Mol Carcinog. 2018 Nov;57(11):1458-1466. doi: 10.1002/mc.22869. Epub 2018 Jul 18.
2
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.经济效用：基层医疗环境中用于精神卫生保健的组合药物基因组学与药物成本节约
Clin Ther. 2017 Mar;39(3):592-602.e1. doi: 10.1016/j.clinthera.2017.01.022. Epub 2017 Feb 21.
3
Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility.心理健康领域中组合基因与个体基因药物基因组学检测：关于背景及临床效用影响的观点
Yale J Biol Med. 2015 Nov 24;88(4):375-82. eCollection 2015 Dec.
4
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin.肝素治疗的血小板减少症患者中出血和血栓栓塞事件对院内死亡率的影响
Am J Cardiol. 2009 Jul 15;104(2):292-7. doi: 10.1016/j.amjcard.2009.03.034. Epub 2009 Jun 3.
5
Polymorphisms of human N-acetyltransferases and cancer risk.人类N-乙酰基转移酶的多态性与癌症风险
Curr Drug Metab. 2008 Jul;9(6):520-31. doi: 10.2174/138920008784892083.
6
Combinatorial pharmacogenetics.组合药物遗传学
Nat Rev Drug Discov. 2005 Nov;4(11):911-8. doi: 10.1038/nrd1874.
7
N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis.N-乙酰转移酶遗传学及其在芳香族和杂环胺诱导致癌易感性中的作用。
Toxicol Lett. 2000 Mar 15;112-113:349-56. doi: 10.1016/s0378-4274(99)00226-x.
8
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.重组人NAT1和多态性NAT2乙酰基转移酶对芳胺致癌物的代谢激活与失活作用。
Carcinogenesis. 1993 Aug;14(8):1633-8. doi: 10.1093/carcin/14.8.1633.
Zotero 插件